Mechanism of Disease (2:09 min)
An overview of the role of KRAS G12C in cancer
Videos and podcasts
Mechanism of Disease (2:09 min)
An overview of the role of KRAS G12C in cancer
The Evolving Landscape of Biomarkers in NSCLC (00:59 seconds)
A short educational video on the evolving landscape of biomarker testing in NSCLC providing an overview of actionable biomarkers
KRAS G12C is a Molecular Biomarker in NSCLC (00:48 seconds)
A short educational video providing an overview of the KRAS gene and the KRAS G12C mutation
Clinical Guidelines Recommend Biomarker Testing in All Appropriate Patients With NSCLC (1:15 min)
A short educational video on comprehensive biomarker testing in NSCLC and clinical guideline recommendations
Biomarkers Can Be Detected Using Either Tissue or Liquid Biopsy Samples (1:13 min)
A short educational video describing how biomarkers can be detected using either liquid or tissue biopsies and how to interpret results
Comprehensive Biomarker Testing is a Key Component to the Care of Patients With Advanced NSCLC (1:16 min)
A short educational video describing the value of comprehensive biomarker testing and the importance of knowing your patient's biomarker status in NSCLC
Leading the Way in NSCLC Biomarker Testing: An Educational Resource for Advanced Practice Providers (9:35 min)
An educational and interactive summary for advanced practice providers (APP) that offers insight into testing considerations, how to set expectations with patients, and receiving and reviewing test results in NSCLC
Featuring Andrew S. Guinigundo, an APP and Director of Precision Oncology at Cincinnati Cancer Advisors
Exploring Biomarker Testing in NSCLC: Actionable Biomarkers and Current Testing Guidelines (3:16 min)
An educational medical short for healthcare professionals about actionable biomarkers, biomarker testing, and current biomarker testing guidelines in advanced NSCLC
Featuring Dr. Ticiana Leal from the Winship Cancer Institute at Emory University School of Medicine
Examining Biomarker Testing Gaps in NSCLC (3:57 min)
An educational medical short for healthcare professionals about guideline recommendations, the benefits of broad biomarker testing, and current biomarker testing patterns and gaps in advanced NSCLC
Featuring Dr. Ticiana Leal from the Winship Cancer Institute at Emory University School of Medicine
Overcoming Biomarker Testing Barriers in NSCLC (5:04 min)
An educational medical short for healthcare professionals about biomarker testing methods, testing barriers, and considerations to overcome testing barriers in advanced NSCLC
Featuring Dr. Ticiana Leal from the Winship Cancer Institute at Emory University School of Medicine
Key Considerations in Biomarker Testing Journey in NSCLC (10:29 min)
A podcast featuring Dr. Pranil K. Chandra, who discusses the importance of testing, practice considerations for tissue preservation, and scenarios where liquid biopsy may be preferred
Considerations for Biomarker Testing in NSCLC (11:00 min)
A podcast featuring Dr. David R. Braxton, who discusses the importance of biomarker testing in clinical practice, improving turnaround time, and strategies for documentation
Have You Tested Your NSCLC Patients for All Actionable Biomarkers? (00:29 seconds)
A short animated video reminding healthcare professionals to test their eligible NSCLC patients for all actionable biomarkers
Downloadable resources for you and your practice
Downloadable resources for your patients
*These third-party resources are for your information only. Amgen does not endorse and is not responsible for the content included in these resources.
KRAS, Kirsten rat sarcoma; NGS, next-generation sequencing; NSCLC, non-small cell lung cancer.